Photo courtesy of Anne Royer Day 13 of 30 This is Anne Royer’s story: Several years ago, we invited our family to a...

Photo courtesy of Anne Royer Day 13 of 30 This is Anne Royer’s story: Several years ago, we invited our family to a...
People with Parkinson’s disease are less able to adapt their movements before crossing obstacles such as mounting a...
The Michael J. Fox Foundation (MJFF) has a growing cache of community exercises, fitness activities, and mental...
Dopamine-releasing cells in the brain, much like most other hormone-producing cells, have a self-regulating feedback...
Photo courtesy of Dave SteinerDay 11 of 30 This is Dave Steiner’s story: html, body { height:100%; width:100%;...
Photo courtesy of Mary Beth Skylis Day 10 of 30 This is Mary Beth Skylis’ story: I was graduating from college when my...
Photo courtesy of Kathy Rupnow Day 9 of 30 This is Kathy Rupnow’s story: Seven years ago, my son was diagnosed with...
BlueRock Therapeutics has received permission from Health Canada to start a Phase 1 clinical trial evaluating DA01, an...
Aptinyx‘s Phase 2 clinical trial evaluating its investigational oral compound NYX-458 for the treatment of cognitive...
I miss the person I was as I dance around the person I am, and I try to figure out who I am becoming. Mine is an...